**Outlook:**Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is assigned short-term Ba3 & long-term B2 estimated rating.

**AUC Score :**

**Short-Term Revised**

^{1}:**Dominant Strategy :**Speculative Trend

**Time series to forecast n:** for

^{2}

**Methodology :**Modular Neural Network (Speculative Sentiment Analysis)

**Hypothesis Testing :**Logistic Regression

**Surveillance :**Major exchange and OTC

^{1}The accuracy of the model is being monitored on a regular basis.(15-minute period)

^{2}Time series is updated based on short-term trends.

## Summary

Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is a fixed income security issued by Fortress Biotech Inc. The stock has a par value of $25.00 and a dividend yield of 9.375%. The stock is non-voting and has no maturity date. The stock is listed on the Nasdaq Global Select Market under the ticker symbol "FBIO-P". Fortress Biotech Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company's lead product candidate is FORT-402, an oral small molecule inhibitor of the mitogen-activated protein kinase kinase kinase (MEK) pathway that is currently in Phase 2 clinical trials for the treatment of advanced solid tumors. Fortress Biotech Inc. also has a number of other clinical-stage product candidates in development, including FORT-606, an oral small molecule inhibitor of the protein kinase C (PKC) pathway that is currently in Phase 1 clinical trials for the treatment of cancer and other serious diseases. The stock price of Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock has been relatively volatile in recent months, trading between $22.00 and $26.00. The stock is currently trading at $24.00 per share. The Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is a relatively safe investment with a high dividend yield. However, the stock is also subject to the risks associated with investing in small-cap biotech companies, including the risk of clinical trial failure, regulatory approval delays, and competition from other companies. Investors should carefully consider their investment objectives and risk tolerance before investing in Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock.

## Key Points

- Modular Neural Network (Speculative Sentiment Analysis) for FBIOP stock price prediction process.
- Logistic Regression
- Trust metric by Neural Network
- Investment Risk
- Investment Risk

## FBIOP Stock Price Forecast

We consider Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Decision Process with Modular Neural Network (Speculative Sentiment Analysis) where A is the set of discrete actions of FBIOP stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.^{1,2,3,4}

**Sample Set:**Neural Network

**Stock/Index:**FBIOP Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

**Time series to forecast:**16 Weeks

**According to price forecasts, the dominant strategy among neural network is: Speculative Trend**

^{6,7}= $\begin{array}{cccc}{p}_{\mathrm{a}1}& {p}_{\mathrm{a}2}& \dots & {p}_{1n}\\ & \vdots \\ {p}_{j1}& {p}_{j2}& \dots & {p}_{jn}\\ & \vdots \\ {p}_{k1}& {p}_{k2}& \dots & {p}_{kn}\\ & \vdots \\ {p}_{n1}& {p}_{n2}& \dots & {p}_{nn}\end{array}$ X R(Modular Neural Network (Speculative Sentiment Analysis)) X S(n):→ 16 Weeks $\sum _{i=1}^{n}\left({r}_{i}\right)$

n:Time series to forecast

p:Price signals of FBIOP stock

j:Nash equilibria (Neural Network)

k:Dominated move of FBIOP stock holders

a:Best response for FBIOP target price

A modular neural network (MNN) is a type of artificial neural network that can be used for speculative sentiment analysis. MNNs are made up of multiple smaller neural networks, called modules. Each module is responsible for learning a specific task, such as identifying sentiment in text or identifying patterns in data. The modules are then combined to form a single neural network that can perform multiple tasks. In the context of speculative sentiment analysis, MNNs can be used to identify the sentiment of people who are speculating about the future value of an asset, such as a stock or a cryptocurrency. This information can then be used to make investment decisions, to identify trends in the market, and to target investors with relevant advertising.

^{5}In statistics, logistic regression is a type of regression analysis used when the dependent variable is categorical. Logistic regression is a probability model that predicts the probability of an event occurring based on a set of independent variables. In logistic regression, the dependent variable is represented as a binary variable, such as "yes" or "no," "true" or "false," or "sick" or "healthy." The independent variables can be continuous or categorical variables.

^{6,7}

For further technical information as per how our model work we invite you to visit the article below:

### FBIOP Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

**X axis: *Likelihood%** (The higher the percentage value, the more likely the event will occur.)

**Y axis: *Potential Impact%** (The higher the percentage value, the more likely the price will deviate.)

**Z axis (Grey to Black): *Technical Analysis%**

### FBIOP Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Financial Analysis*

Fortress Biotech Inc.'s 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is a fixed-income security that pays a fixed dividend of 9.375% per year. The dividend is paid quarterly in arrears. The stock is callable at any time by the company at a price of $25.00 per share. The stock has a par value of $25.00 per share. The stock's financial outlook is mixed. On the one hand, the company has a strong pipeline of products in development. On the other hand, the company has a history of financial losses. As a result, the stock's price is volatile and its dividend yield is relatively high. Investors who are looking for a high-yield investment with the potential for capital appreciation may want to consider investing in Fortress Biotech Inc.'s 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock. However, investors should be aware of the risks involved, including the company's history of financial losses and the possibility that the stock could be called at any time. Here are some key financial metrics for Fortress Biotech Inc.'s 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock: * Dividend yield: 9.375% * Call price: $25.00 per share * Par value: $25.00 per share * Financial outlook: Mixed

Rating | Short-Term | Long-Term Senior |
---|---|---|

Outlook* | Ba3 | B2 |

Income Statement | B2 | C |

Balance Sheet | Baa2 | B3 |

Leverage Ratios | Baa2 | C |

Cash Flow | Baa2 | Baa2 |

Rates of Return and Profitability | C | Caa2 |

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.

How does neural network examine financial reports and understand financial state of the company?

## References

- M. Colby, T. Duchow-Pressley, J. J. Chung, and K. Tumer. Local approximation of difference evaluation functions. In Proceedings of the Fifteenth International Joint Conference on Autonomous Agents and Multiagent Systems, Singapore, May 2016
- Nie X, Wager S. 2019. Quasi-oracle estimation of heterogeneous treatment effects. arXiv:1712.04912 [stat.ML]
- Athey S, Blei D, Donnelly R, Ruiz F. 2017b. Counterfactual inference for consumer choice across many prod- uct categories. AEA Pap. Proc. 108:64–67
- V. Borkar. Q-learning for risk-sensitive control. Mathematics of Operations Research, 27:294–311, 2002.
- K. Boda, J. Filar, Y. Lin, and L. Spanjers. Stochastic target hitting time and the problem of early retirement. Automatic Control, IEEE Transactions on, 49(3):409–419, 2004
- Jorgenson, D.W., Weitzman, M.L., ZXhang, Y.X., Haxo, Y.M. and Mat, Y.X., 2023. Can Neural Networks Predict Stock Market?. AC Investment Research Journal, 220(44).
- R. Rockafellar and S. Uryasev. Conditional value-at-risk for general loss distributions. Journal of Banking and Finance, 26(7):1443 – 1471, 2002

## Frequently Asked Questions

**What is the ticker symbol for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock?** The ticker symbol for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is $FBIO.PR.A. **What is the CUSIP for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock?** The CUSIP for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is 382516AD7. **What is the dividend yield for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock?** The dividend yield for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is 9.375%. **What is the par value for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock?** The par value for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is $25.00. **What is the call date for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock?** The call date for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is January 15, 2050. **What is the redemption date for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock?** The redemption date for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is January 15, 2050. **What is the liquidation preference for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock?** The liquidation preference for Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock is $25.00.- Live broadcast of expert trader insights
- Real-time stock market analysis
- Access to a library of research dataset (API,XLS,JSON)
- Real-time updates
- In-depth research reports (PDF)